Evidence map›Paper›PMID 37496784›Full record

ArticleCJC open2023

Incidence of Atrial Fibrillation as the Initial Manifestation of Cardiac Sarcoidosis: Insights From a Catheter Ablation Registry.

Alessandro De Bortoli, Willy Weng, Anahita Tavoosi, Pablo Nery, Rob Beanlands, Calum Redpath, Girish Nair, Andres Klein, Mehrdad Golian, Simon Hansom and 6 more

Open access · goldAbstract read
In one paragraph

Article in CJC open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 2 countries.

Alessandro De BortoliDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Willy WengDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Anahita TavoosiDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Pablo NeryDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Rob BeanlandsDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Calum RedpathDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Girish NairDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Andres KleinDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Mehrdad GolianDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Simon HansomDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
F Daniel RamirezDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Carole DennieDepartment of Radiology, The Ottawa Hospital, Ottawa, Ontario, Canada.
Benjamin Joe Wade ChowDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Riley J ArseneauDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Angela LuethDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
David H BirnieDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
University of Ottawa · CAOttawa Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cardiac sarcoidosis (CS) is a rare form of arrhythmogenic cardiomyopathy; a delayed diagnosis can lead to significant consequences. Patients with clinically manifest CS often have minimal extracardiac involvement and thus frequently present initially to cardiology. Indeed, certain specific arrhythmic scenarios should trigger investigations for undiagnosed CS. Atrial fibrillation (AF) has been described as one of the presenting features of CS; however, the incidence of this presentation is not known. Methods: At our institution, cardiac computerized tomography is routinely performed prior to catheter ablation for AF. Noncardiac incidental findings are described by radiologists and are followed-up by interval investigations. We systematically reviewed noncardiac reports from 1574 consecutive patients in our prospective AF ablation registry. Specifically, we used text-scraping techniques to search on the following keywords: "adenopathy" and "sarcoidosis." Detailed chart review of identified cases was then performed to evaluate results of interval investigations and assess long-term outcomes. Results: Twenty of 1574 patients (1.3%) had noncardiac reports containing "adenopathy" and/or "sarcoidosis." After interval imaging and a follow-up period averaging 60 ± 35 months, only 2 patients of 1574 (0.13%) were diagnosed with CS. Four of 20 (20%) had a previous history of extracardiac sarcoidosis, and another 1 of 20 (5%) was subsequently diagnosed with extracardiac sarcoidosis. However, none of these 5 patients had evidence of cardiac involvement. Conclusions: CS is a rare finding among patients undergoing a first-time AF ablation. Our findings suggest that AF is an uncommon initial presentation of CS. Thus, investigations for CS in patients with AF are not warranted routinely, unless additional suggestive clinical features are present.

Identifiers

PMID37496784
PMCPMC10366630
OpenAlexW4366526239

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.